References
- Carvalho KR, Carvalho-Assef AP, Peirano G, Galvao dos Santos LC, Pereira MJ, Asensi MD. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying blaOXA-23 collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 2009;34:25–8.
- Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J 2011;52:879–91.
- Kempf M, Rolain J. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012;39:105–14.
- Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006;57:373–83.
- Runnegar N, Sidjabat H, Sharon Goh HM, Nimmo GR, Schembri MA, Paterson DL. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol 2010;48:4051–6.
- Yan Z, Shen D, Cao J, Chen R, Wei X, Liu L, . Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. Int J Antimicrob Agents 2010;35:269–73.
- Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. M100-S19. Wayne, PA: CLSI; 2009.
- Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, . Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351–3.
- Qi C, Malczynski M, Parker M, Scheetz MH. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol 2008;46:1106–9.
- Owen RJ, Li J, Nation RL, Spelman D. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2007;59:473–7.
- Pillar CM, Torres MK, Brown NP, Shah D, Sham DF. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by Gram-negative bacteria, against recent clinical isolates from the United States. Antimicrob Agents Chemother 2008;52:4388–99.
- Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010;16:35–40.
- Kim C, Lee Y, Lee H, Woo G, Song W, Kim M, . Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 2010;68:432–8.
- Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, −24/40 and −58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother 2009;63:55–9.
- D’Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 2011;66:54–61.
- Gur D, Korten V, Unal S, Lalitagauri MD, Castanheira M. Increasing carbapenem resistance due to clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY program sites. J Med Microbiol 2008;57:1529–32.
- Carretto E, Barbarini D, Farina C, Grosini A, Nicoletti P, Manso E. Use of the DiversiLab semiautomated repetitive-sequence-based polymerase chain reaction for epidemiologic analysis on Acinetobacter baumannii isolates in different Italian hospitals. Diagn Microbiol Infect Dis 2008;60:1–7.
- Grisold AJ, Zarfel G, Strenger V, Feierl G, Leirner E, Masoud L, . Use of automated repetitive-sequence based PCR for rapid laboratory confirmation of nosocomial outbreaks. J Infect 2010;60:44–51.
- Fontana C, Favaro M, Minelli S, Bossa MC, Testore GP, Leonardis F, . Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect Dis 2008;8:79–88.
- Baang JH, Axelrod P, Decker BK, Hujer AM, Dash G, Truant AR, . Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital. Am J Infect Control 2012;40:134–7.
- Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010;35:219–26.